SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-22-031695
Filing Date
2022-12-12
Accepted
2022-12-09 19:01:05
Documents
18
Period of Report
2022-12-10
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K sgmo-20221210.htm   iXBRL 8-K 60770
5 GRAPHIC sgmo-20221210_g1.jpg GRAPHIC 539826
6 GRAPHIC sgmo-20221210_g2.jpg GRAPHIC 1201323
7 GRAPHIC sgmo-20221210_g3.jpg GRAPHIC 494898
8 GRAPHIC sgmo-20221210_g4.jpg GRAPHIC 127401
9 GRAPHIC sgmo-20221210_g5.jpg GRAPHIC 587853
10 GRAPHIC sgmo-20221210_g6.jpg GRAPHIC 1364922
  Complete submission text file 0001628280-22-031695.txt   9489761

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sgmo-20221210.xsd EX-101.SCH 1941
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sgmo-20221210_lab.xml EX-101.LAB 24132
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sgmo-20221210_pre.xml EX-101.PRE 12545
12 EXTRACTED XBRL INSTANCE DOCUMENT sgmo-20221210_htm.xml XML 11309
Mailing Address 7000 MARINA BLVD BRISBANE CA 94005
Business Address 7000 MARINA BLVD BRISBANE CA 94005 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

IRS No.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30171 | Film No.: 221455886
SIC: 2836 Biological Products, (No Diagnostic Substances)